Pharma AI 2026: Phase II, FDA Trials, and the $1B Stack

Pharma AI 2026: Phase II, FDA Trials, and the $1B Stack Pharma AI crossed a quiet but consequential threshold in early 2026. INS018_055, a TNIK inhibitor whose target was identified by AI and whose molecular structure was generated by AI, posted stat...